Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06981624

Comparison of the Systematic Versus the Selective Use of Heparin for the Prevention of Radial Artery Occlusion

Randomized study comparing the systematic use of heparin (standard of care) against an elective use of heparin to prevent radial artery occlusion after a percutaneous catheterization using a dual-artery compression system.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Radial Artery Occlusion Arterial Occlusive Diseases Cardiovascular Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Any patient referred for a diagnostic transradial catheterism

Exclusion criteria

  • Unable to understand study design or provide informed consent
  • Unable to receive antiplatelet therapy with aspirina and/or clopidogrel-prasugrel and/or ticagrelor and intravenous anticoagulant derived from heparine or bivalirudine
  • Local condition such as hematoma or pseudo-aneurims precluding radial or ulnar access.
  • Presence of plethysmographic waveform with simultaneous radial and ulnar occlusive compression (due to colaterals or interouseous artery) precluding the evaluation of patent hemostasis.

Treatment and study plan

No heparin

Other

Hemostasis achieved using a dual-artery compression device without administration of heparin after trans-radial diagnostic catheterization

Primary outcomes

  1. Rates of patent hemostasis

    Time frame: within 24 hours after diagnostic angiography

    Evaluation of patent hemostasis by pulse oximetry

  2. Time to hemostasis

    Time frame: within 24 hours post-procedure

  3. Nursing time involvement

    Time frame: within 24 hours post-procedure

    Calculation of nursing time required for surveillance and care of hemostasis

  4. Evaluation of complications

    Time frame: within 30 days of procedure

    Compilation of access site complications such as radial artery occlusion, bleeding, presence and grading of hematomas, etc.

Study contacts

Contact information is provided by the study sponsor or research team.

Michele Jadin

CONTACT

[email protected]

418-656-8711

Sponsors and collaborators

Lead sponsor

Olivier F. Bertrand

Other

Registry information

Official study title

Comparaison d'un Traitement systématique à l'héparine Versus sélectif Pour la prévention de l'Occlusion Radiale EASY-Héparine

Acronym: EASY-Heparin

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
May 21, 2025
Registry last updated
Jan 26, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.